These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8049655)

  • 21. Restitution of normal marrow morphology and karyotype in acute refractory acute promyelocytic leukaemia with all-trans retinoic acid.
    Creagh MD; Clark DJ; Collin RC
    Br J Haematol; 1991 Aug; 78(4):572. PubMed ID: 1911349
    [No Abstract]   [Full Text] [Related]  

  • 22. Probing the pathobiology of response to all-trans retinoic acid in acute promyelocytic leukemia: premature chromosome condensation/fluorescence in situ hybridization analysis.
    Vyas RC; Frankel SR; Agbor P; Miller WH; Warrell RP; Hittelman WN
    Blood; 1996 Jan; 87(1):218-26. PubMed ID: 8547645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid syndrome in acute promyelocytic leukemia.
    Sentero D; Hosenpud J
    Wis Med J; 1997 Apr; 96(4):35-8. PubMed ID: 9128433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
    Escudier SM; Kantarjian HM; Estey EH
    Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients.
    Chen ZX; Xue YQ; Zhang R; Tao RF; Xia XM; Li C; Wang W; Zu WY; Yao XZ; Ling BJ
    Blood; 1991 Sep; 78(6):1413-9. PubMed ID: 1884013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity of tretinoin in acute promyelocytic leukaemia.
    Schmitt K; Schwarz R; Tulzer G; Krieger O; Zoubek A; Gadner H
    Lancet; 1994 Feb; 343(8893):361. PubMed ID: 7905174
    [No Abstract]   [Full Text] [Related]  

  • 27. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience.
    Warrell RP; Maslak P; Eardley A; Heller G; Miller WH; Frankel SR
    Leukemia; 1994 Jun; 8(6):929-33. PubMed ID: 8207986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A recently recognized entity associated with the treatment of acute promyelocytic leukemia: the retinoic acid syndrome.
    Marinakis T; Papadimitriou CA; Koufos C; Fertakis A
    Haematologica; 1993; 78(3):192-4. PubMed ID: 8375752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report: all-trans retinoic acid, hyperleukocytosis, and marrow infarction.
    Lopez P; Hayne O
    Am J Hematol; 1992 Dec; 41(4):305-6. PubMed ID: 1288302
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of trans-retinoic acid in the treatment of acute promyelocytic leukemia.
    Dulaney AM; Murgatroyd RJ
    Ann Pharmacother; 1993 Feb; 27(2):211-4. PubMed ID: 8439701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasculitis associated with all trans retinoic acid (ATRA) in a case with acute promyelocytic leukemia.
    Paydas S; Yavuz S; Disel U; Sahin B; Canbolat T; Tuncer I
    Leuk Lymphoma; 2003 Mar; 44(3):547-8. PubMed ID: 12688331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Chen GQ; Shen ZX; Wu F; Han JY; Miao JM; Zhong HJ; Li XS; Zhao JQ; Zhu J; Fang ZW; Chen SJ; Chen Z; Wang ZY
    Leukemia; 1996 May; 10(5):825-8. PubMed ID: 8656678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary leukostasis secondary to all-trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse.
    Vosburgh E
    Leukemia; 1992 Jun; 6(6):608-10. PubMed ID: 1602800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Australian Leukaemia Study Group.
    Wiley JS; Firkin FC
    Leukemia; 1995 May; 9(5):774-8. PubMed ID: 7769839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?
    Dombret H; Geiger S; Daniel MT; Glaisner S; Micléa JM; Castaigne S; Merle-Beral H; Lacombe C; Chomienne C; Degos L
    Leukemia; 1995 Sep; 9(9):1473-7. PubMed ID: 7658714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide.
    Camacho LH; Soignet SL; Chanel S; Ho R; Heller G; Scheinberg DA; Ellison R; Warrell RP
    J Clin Oncol; 2000 Jul; 18(13):2620-5. PubMed ID: 10893295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Remission of acute promyelocytic leukemia after all-trans-retinoic acid].
    Knobel B; Sommer I; Meytes D
    Harefuah; 1992 Dec; 123(11):445-8, 507. PubMed ID: 1487198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoic acids in the treatment of acute promyelocytic leukemia.
    Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.